Healthcare • Drug Manufacturers - General
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if LLY is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
587 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 57 days ago
Red flags: 3
4,646 filers reported a long position in LLY for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| LILLY ENDOWMENT INC | $108.4B | 90.4M | -1.7% |
| BlackRock, Inc. | $81B | 67.5M | +1.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $64.2B | 53.5M | +0.3% |
| STATE STREET CORP | $43.4B | 36.2M | +1.7% |
| FMR LLC | $34.1B | 28.5M | +8.1% |
| Capital Research Global Investors | $25B | 20.9M | -15.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $25B | 20.9M | -0.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $24.3B | 20.3M | +0.6% |
| MORGAN STANLEY | $19.5B | 16.2M | +5.1% |
| Capital World Investors | $19.1B | 15.9M | +1.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.